title: [Optimization of animal model for investigation of pathogenesis of type 2 diabetes].
abstract: Diabetes mellitus is one of the three most common modem diseases. A number of animal models is used in investigations of the mechanisms of development of the disease. Most of these models replicate the symptoms of type 1 diabetes mellitus. The development of type 2 diabetes is caused by the insulin resistance, hyperglycemia, structural and functional disorders of the pancreatic cells. Investigation of pathogenesis of type 2 diabetes is complicated by the lack of adequate models of this disease. In this work, based on existing hyperglycemia model, we propose the model of metabolic syndrome as a precursor of type 2 diabetes. The development of metabolic syndrome symptoms was caused by 28 days long intramuscular injection of protamine sulfate to guinea pigs at a dose of 15 mg/kg along with keeping of animals on a high glucose diet. Increased blood glucose and cholesterol levels, reduction of glycogen in liver, the structural and functional damage and reduce in the number of functionally active beta-cells in the pancreas of the experimental animals were observed. The results confirm the development of the metabolic syndrome symptoms in experimental animals, which makes it possible to use such methodical approach in creation of promising type 2 diabetes model.
authors.forename: V V
authors.initials: VV
authors.lastname: Rushchak
authors.forename: V M
authors.initials: VM
authors.lastname: Kovalenko
authors.forename: A K
authors.initials: AK
authors.lastname: Voronina
authors.forename: V O
authors.initials: VO
authors.lastname: Kitam
authors.forename: O V
authors.initials: OV
authors.lastname: Maksymchuk
authors.forename: M O
authors.initials: MO
authors.lastname: Chashchyn
mesh_terms: D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology*; D004032:Diet; D004195:Disease Models, Animal; D005947:Glucose / Q000008:administration & dosage* / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006168:Guinea Pigs; D006943:Hyperglycemia / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology*; D007273:Injections, Intramuscular; D007333:Insulin Resistance; D050417:Insulin-Secreting Cells / Q000378:metabolism / Q000473:pathology*; D008099:Liver / Q000378:metabolism; D008297:Male; D024821:Metabolic Syndrome / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology*; D011479:Protamines
chemical_list: D011479:Protamines; D006003:Glycogen; D005947:Glucose